EP3252069
(11.beta.,17.beta.)-17-hýdroxý-11-[4-(metýlsúlfónýl)fenýl]-17-(pentalflúrmetýl)estra-4,9-díen-3-ón til að nota við að meðhöndla af sjúkdóma
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.7.2010EP published:
3.4.2019EP application number:
17176264.4
EP translation filed:
12.6.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
6.7.2030Expiry date:
6.7.2023
Title:
(11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULFONYL)PHENYL]-17-(PENTALFUOROMETHYL)ESTRA-4,9-DIEN-3-ONE FOR USE IN THE TREATMENT OF DISEASES
Timeline
Today
7.7.2010EP application
3.4.2019EP Publication
12.6.2019Translation submitted
15.7.2019Registration published
6.7.2023Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353, Berlin, DE
Inventor
Name:
Schwede, WolfgangAddress:
Glienicke, DE
Name:
Klar, UlrichAddress:
Berlin, DE
Name:
Möller, CarstenAddress:
Berlin, DE
Name:
Rotgeri, AndreaAddress:
Berlin, DE
Name:
Bone, WilhelmAddress:
Berlin, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
102009034362Date:
20.7.2009Country:
DE
Classification
Categories:
C07J 31/00, C07J 41/00, A61K 31/567, A61P 5/36, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 25.6.2019
Expires: 6.7.2020
Payer: Árnason Faktor
Number: 11
Paid: 25.6.2020
Expires: 6.7.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.6.2021
Expires: 6.7.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 29.6.2022
Expires: 6.7.2023
Payer: Árnason Faktor ehf.